Skip to main content
TBI
NYSE Trade & Services

TrueBlue Reports Wider Q4 Net Loss and Sharp Adjusted EBITDA Decline Amid Revenue Growth

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$3.85
Mkt Cap
$135.326M
52W Low
$3.45
52W High
$7.86
Market data snapshot near publication time

summarizeSummary

TrueBlue, Inc. reported an increased net loss and a significant drop in Adjusted EBITDA for Q4 2025, despite an 8% rise in revenue, alongside a challenging Q1 2026 outlook for gross margin.


check_boxKey Events

  • Q4 2025 Net Loss Widens Significantly

    Net loss for Q4 2025 increased to $32 million, up from $12 million in the prior year period, primarily due to an $18 million non-cash impairment charge on right-of-use and long-lived assets.

  • Adjusted EBITDA Declines Sharply

    Adjusted EBITDA fell by 73% to $2 million in Q4 2025, compared to $9 million in Q4 2024, indicating significant operational profitability challenges.

  • Revenue Growth Achieved

    The company reported an 8% increase in Q4 2025 revenue to $418 million, with organic revenue growing by 5%, driven by momentum in skilled businesses.

  • Gross Margin Contracts

    Gross margin decreased by 5 percentage points, primarily due to lower workers' compensation benefit from prior year reserves and changes in business mix.


auto_awesomeAnalysis

TrueBlue's fourth-quarter results present a mixed picture, with revenue growth overshadowed by a substantially wider net loss and a sharp decline in Adjusted EBITDA. The $18 million non-cash impairment charge significantly impacted the net loss, while gross margin contraction points to underlying operational pressures. Although the company achieved organic revenue growth and improved SG&A, the overall profitability metrics deteriorated. The Q1 2026 outlook anticipates continued revenue growth but also a further decline in gross margin. These results are particularly critical given the ongoing proxy contest initiated by EHS Management, as they will heavily influence investor sentiment and the company's strategic defense.

At the time of this filing, TBI was trading at $3.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $135.3M. The 52-week trading range was $3.45 to $7.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed TBI - Latest Insights

TBI
Apr 14, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
TBI
Apr 13, 2026, 8:08 AM EDT
Filing Type: 8-K
Importance Score:
8
TBI
Mar 03, 2026, 5:30 PM EST
Filing Type: DEFA14A
Importance Score:
8
TBI
Feb 18, 2026, 4:49 PM EST
Filing Type: 10-K
Importance Score:
8
TBI
Feb 18, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
TBI
Feb 03, 2026, 5:02 PM EST
Filing Type: 8-K
Importance Score:
9
TBI
Jan 20, 2026, 1:26 PM EST
Filing Type: DFAN14A
Importance Score:
9
TBI
Jan 12, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
TBI
Jan 08, 2026, 8:49 PM EST
Filing Type: DEFA14A
Importance Score:
8
TBI
Jan 08, 2026, 8:44 PM EST
Filing Type: DEFA14A
Importance Score:
8